Lab evidence published 12 May shows the H5N1 strain dominant in US dairy cattle replicates more efficiently in human nasal tissue and partly evades innate immune defence. Idaho's dairy outbreak surged to 59 quarantined herds and the national US total crossed 1,047, the same week USDA ended mandatory interstate cattle testing. The MV Hondius Andes hantavirus cluster grew to 11 cases across 6 countries, prompting a UK military supply drop to a remote South Atlantic island.
B3.13 improves at human noses as US surveillance contracts; the vaccine-sharing treaty remains unsigned.
NIH/NIAID researchers Flagg and Winski published peer-reviewed evidence on 12 May that the H5N1 strain dominating US dairy cattle replicates more efficiently in human nasal epithelium than any historical H5N1 strain and partly disables the immune alarm that would normally limit early replication.
A peer-reviewed study in CDC Emerging Infectious Diseases on 12 May found that B3.13, the dominant H5N1 strain in US dairy cattle, replicates more efficiently in human nasal tissue than earlier H5N1 strains and partially disables the body's first-line immune alarm.
Two-thirds of dairy farm workers tested already carry antibodies from the 2009 swine flu pandemic, which researchers believe is suppressing human case counts for now.
USDA APHIS ended mandatory pre-movement H5N1 testing for lactating dairy cattle travelling interstate from states without confirmed outbreaks on 1 May, the same day Idaho recorded its first infected herd.
The US Department of Agriculture ended mandatory H5N1 testing for dairy cattle moving between states on 1 May 2026, the same day Idaho confirmed its first herd (ID:3108). USDA APHIS said its milk surveillance network made movement testing redundant.
The rollback removed the only checkpoint that caught infections during interstate cattle transfers, at the moment the fastest-escalating state in the outbreak began its surge.
South Central Idaho's dairy H5N1 tally reached 59 quarantined herds and 86 individual cattle confirmations across four counties by 12 May, up from a single confirmed herd on 1 May, making Idaho the second-highest state nationally. H5N1 was also confirmed in domestic cats in Washington and Oregon, and alpacas in Idaho.
Idaho's H5N1 dairy outbreak grew from one confirmed herd on 1 May 2026 to 59 quarantined herds across four counties in South Central Idaho by 12 May, with 86 individual cattle confirmed. The virus also reached domestic cats in Washington and Oregon and alpacas in Idaho.
Idaho is now the second-highest state in the national total of 1,047 confirmed cases, and the mammalian host range is widening at the same time as a key surveillance layer was removed.
CDC issued Health Alert Network advisory HAN00528 on 8 May requiring airborne infection isolation for all suspected Andes hantavirus patients in the United States, routing repatriates to a specialist Nebraska biocontainment facility and noting that ECMO can raise Andes survival to approximately 80% if started early.
The UK repatriated 20 British nationals from Tenerife to Arrowe Park Hospital in Wirral on 10 May 2026 for 45-day Andes hantavirus isolation. A further suspected case on Tristan da Cunha, a remote South Atlantic island with no hospital, required a military parachute drop of medical supplies.
The operation exposed the reach of the UK's overseas territory medical obligations and tested repatriation logistics for a pathogen with person-to-person transmission risk.
UKHSA confirmed on 11 May that 20 British nationals were admitted to Arrowe Park Hospital in Wirral for 45-day isolation following the MV Hondius Andes hantavirus cluster, while the UK military conducted a parachute supply drop to Tristan da Cunha for a suspected case on an island with no hospital.
SwitzerlandWHO revised its Disease Outbreak News on 9 May 2026, upgrading the risk for the MV Hondius Andes hantavirus cluster from LOW to MODERATE. All six laboratory-confirmed cases tested positive for Andes virus by PCR. Total cases reached eight, with three deaths and a 38% case-fatality rate, across six countries.
The upgrade followed the Swiss Andes strain confirmation (ID:3106) and marks the first formal WHO risk reclassification for this cluster.
WHO revised Disease Outbreak News 600 on 9 May, upgrading the ship-level risk for the MV Hondius Andes hantavirus cluster from LOW to MODERATE and confirming all six laboratory-tested cases as Andes virus by PCR and sequencing, with a 38% case-fatality rate across 8 cases and 3 deaths.
The US Centers for Disease Control issued Health Alert Network advisory HAN00528 on 8 May 2026, requiring airborne infection isolation for all suspected Andes hantavirus patients in the United States. This is a more protective level than the standard droplet precautions used for other hantaviruses.
The advisory also reported that ECMO life-support technology raises Andes survival to around 80% if started early, and directed US patients to a specialist facility in Nebraska.
ECDC published a 12 May surveillance update recording 11 MV Hondius cases across six countries, three higher than the 8 reported in WHO's revised DON 600 on 9 May, with a three-day reporting lag the most likely explanation for the discrepancy.
The European Centre for Disease Prevention and Control published its 12 May 2026 Andes hantavirus update with 11 total cases, three more than WHO's count of eight in the revised DON 600 from 9 May. Both agencies draw on the same national reports from six affected countries.
The gap most likely reflects a reporting lag of two to three days, but differing case-definition thresholds between national health authorities feeding the two systems could also explain it.
WHO member states concluded the resumed 6th IGWG session on 1 May by agreeing to extend negotiations on the PABS annex, leaving the Pandemic Agreement inoperative one year after its adoption at WHA78 and scheduling the next substantive session for 6-17 July 2026.
SwitzerlandWHO member states ended the resumed 6th IGWG meeting on 1 May 2026 by agreeing to extend negotiations on the Pathogen Access and Benefit-Sharing annex to the WHO Pandemic Agreement, adopted at WHA78 in May 2025. The agreement cannot be signed or ratified without this annex resolved.
One year after adoption, the treaty has no legal mechanism for rapid pathogen sharing or equitable vaccine distribution; the 7th negotiating session is scheduled for July 2026.
Sideways with a defined upgrade trigger. The current picture, B3.13 improving in human nasal tissue, CDC human case counter frozen at 71, Idaho surging, mammalian host range widening to cats and alpacas, is a deteriorating steady state rather than an active pandemic signal. The counter is frozen not because exposure has stopped but because CDC's human surveillance for dairy workers has not produced new confirmed cases despite the aerosol and fitness evidence accumulating around them. The tipping mechanism is specific: any confirmed human-to-human B3.13 transmission, or sustained nasal replication in a dairy worker without pdm09 cross-immunity (the 34% not covered by the 66% antibody prevalence documented in the EID paper), would flip pandemic-risk posture from monitoring to active response. The two named decision points that will sharpen the picture before the next briefing cycle are: CDC dairy-worker PPE guidance update, which would signal that the agency has accepted the aerosol-plus-nasal-fitness combination as an occupational hazard requiring upgrade; and WHA79 PABS authorisation (18-23 May), which will either produce a named blocking coalition or extend the opacity that has insulated negotiations from public pressure.
